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Over the last decades, phytotherapy has attained 
new status in the world public health scenario. The 
increasing use of herbal medicines, due at least in 
part to the growth of the elderly population and their 
associated chronic diseases (Grünwald and Buettel, 
1996), has made this market attractive to investors. In 
fact, the global market for herbal medicines stands at 
over USD$ 60 billion annually (Sharma et al., 2008). 
The World Health Organization currently 
recommends and encourages the inclusion of 
traditional herbal medicines in health care programs, 
as these drugs are available at low cost (WHO, 2002, 
2003, 2008). Indeed, following this recommendation, 
and considering the worldwide trend towards such 
treatment, several Latin American countries have 
included medicinal plants and herbal medicines as 
major topics in their health policy agenda. On the 
other hand, the growth of this practice has also been 
cause for concern to authorities monitoring its impact 
on public health. 
Ever since the first issue, BLACPMA has played an 
important role in this context, publishing advances in 
medicinal plant research in Latin America and further 
afield. The special issues dedicated to the regulation 
of herbal medicines [BLACPMA 6(4) in 2007 and 
8(10) in 2009], as well as herb-drug interactions 
[BLACPMA 7(2) and 7(6) in 2008] are examples of 
how this journal is contributing to evidence-based 
herbal medicine use. 
In this vein, the present issue of BLACPMA 
contains several interesting papers covering 
ethnomedicine, phytotherapy and herbal medicine in 
Latin America. One paper addresses the lack of 
regulation in a medicinal plant market, where several 
problems such as lack of quality, incorrect labeling 
and misidentified species were identified.  
Another recurrent situation in Latin America is 
the increasing use of foreign plant species by local 
communities, rather than native ones. The 
introduction of heavily advertised, and more 
expensive, transnational herbal preparations, has led 
to a decline in the use of local traditional remedies. 
However, advances in herbal drug research at a 
national level are combating this decline. 
Government financing agencies have helped to 
stimulate studies into the efficacy of native plant 
species and there is an effort by several research 
groups to scale up the production of local medicinal 
plants stimulating domesticated crop production and 
developing new techniques to improve the quality 
control and manufacturing processes for the 
production of herbal medicines derived from local 
species. 
Latin American regulatory agencies have been 
discussing the possibility of harmonizing the 
regulation of herbal medicine, within the framework 
of the Pan American Network of Drug Regulatory 
Harmonization (PANDRH). Mercosur has been 
promoting international seminars on herbal medicines 
(MERCOFITO). In the last 2 months, the Brazilian 
health minister has published several normative 
documents on herbal drugs and medicines in order to 
improve the quality, efficacy and safety of the 
products available in the Brazilian market. 
Nevertheless, there is still plenty of work to be done 
in the medicinal plant field. The editorial board of 
BLACPMA invites Latin American and medicinal 
plants researchers throughout the world to contribute 
to the development of effective, safe and accessible 
phytotherapy. 
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